BCI
GMED icon

Blue Capital Inc’s Globus Medical GMED Stock Holding History

Blue Capital Inc’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,500
Closed -$443K – 100
2025
Q2 		$443K Buy
+7,500
New +$485K 0.31% 63
2024
Q4 		$620K Buy
+7,500
New +$592K 0.44% 61

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Blue Capital Inc's GMED Position: Q3 2025 in Review

Blue Capital Inc sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 7,500 shares — an estimated $443K sold.

Blue Capital Inc first reported a position in GMED in Q4 2024 and held it in 2 quarters. The position peaked at $620K in Q4 2024. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Blue Capital Inc reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Blue Capital Inc sold 7,500 Globus Medical shares in Q3 2025, an estimated $443K.
  • Blue Capital Inc first reported a position in Globus Medical in Q4 2024 and held it in 2 quarters.
  • Blue Capital Inc's Globus Medical position peaked at $620K in Q4 2024.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Blue Capital Inc's 13F filing for Q3 2025, filed 14 Nov 2025.